|
業務類別
|
Biotechnology |
|
業務概覽
|
PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The company views its operations and manages its business in one operating segment: life science, which is focused on the discovery, development and commercialization of the company's clinicallydifferentiated medicines that provide benefits to patients with rare disorders. |
| 公司地址
| 500 Warren Corporate Center Drive, Warren, NJ, USA, 07059 |
| 電話號碼
| +1 908 222-7000 |
| 傳真號碼
| +1 908 222-7231 |
| 公司網頁
| https://www.ptcbio.com |
| 員工數量
| 1047 |
| Mr. Mark E. Boulding |
Executive Vice President and Chief Legal Officer |
-- |
30/04/2025 |
| Ms. Christine Utter |
Senior Vice President, Chief Accounting Officer and Head, People Services |
-- |
19/02/2026 |
| Dr. Neil Almstead, PhD |
Chief Technical Operations Officer |
美元 560.60K |
30/04/2025 |
| Mr. Eric Pauwels |
Chief Business Officer |
美元 570.22K |
30/04/2025 |
| Dr. Lee Scott Golden, M.D. |
Executive Vice President and Chief Medical Officer |
美元 548.33K |
30/04/2025 |
| Mr. Pierre Gravier |
Chief Financial Officer |
美元 542.50K |
19/02/2026 |
| Dr. Matthew B. Klein, F.A.C.S.,M.D.,M.S. |
Director and Chief Executive Officer |
美元 882.17K |
19/02/2026 |
|
|
| Ms. Stephanie S. Okey, M.S. |
Independent Director |
19/02/2026 |
| Ms. Alethia Young |
Independent Director |
19/02/2026 |
| Ms. Mary Smith |
Independent Director |
19/02/2026 |
| Ms. Emma Reeve |
Independent Director |
19/02/2026 |
| Dr. Allan Jacobson, PhD |
Independent Director |
19/02/2026 |
| Dr. Jerome Bernard Zeldis, M.D.,PhD |
Independent Director |
19/02/2026 |
| Mr. David P. Southwell |
Independent Director |
19/02/2026 |
| Dr. Matthew B. Klein, F.A.C.S.,M.D.,M.S. |
Director and Chief Executive Officer |
19/02/2026 |
| Dr. Glenn D. Steele, M.D., Ph.D. |
Independent Director |
19/02/2026 |
| Mr. Michael Schmertzler |
Chairman of the Board |
19/02/2026 |
|
|
|
|
